World's Best Scientists 2026 revealed!
Nancy J. Sullivan

Nancy J. Sullivan

D-Index & Metrics

Microbiology

D-Index
64
Citations
18767
World Ranking
2580
National Ranking
1038

Nancy J. Sullivan publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Nancy J. Sullivan sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 125 publications — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Nancy J. Sullivan D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Nancy J. Sullivan sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 64 D-Index — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Nancy J. Sullivan is affiliated with Boston University in the United States. Their research primarily focuses on the field of Medicine, with a significant emphasis on Infectious Diseases. Other subfields of study include Molecular Biology, Epidemiology, Animal Science and Zoology, and Immunology.

The areas of research coverage prominently include:

  • SARS-CoV-2 and COVID-19 Research
  • Viral Infections and Outbreaks Research
  • COVID-19 Clinical Research Studies
  • Viral Infections and Vectors
  • Animal Virus Infections Studies
  • Viral gastroenteritis research and epidemiology
  • Immunotherapy and Immune Responses

The scientist has published extensively across several influential scientific journals and preprint archives. Frequent publication venues are:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Science
  • Science Translational Medicine
  • New England Journal of Medicine
  • Cell Reports

Nancy J. Sullivan's recent notable papers include:

  • Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates, 2020, New England Journal of Medicine
  • SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters, 2022, Nature
  • Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine, 2021, New England Journal of Medicine
  • LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants, 2022, Cell Reports
  • Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates, 2021, Science

The scientist has collaborated frequently with several co-authors, including:

  • John R. Mascola
  • Lingshu Wang
  • Juan I. Moliva
  • Barney S. Graham
  • Peter D. Kwong

Best Publications

  • Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.

    Kizzmekia S Corbett;Barbara Flynn;Kathryn E Foulds;Joseph R Francica

  • SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters

    Unknown

  • Endosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for Infection

    Kartik Chandran;Nancy J. Sullivan;Ute Felbor;Sean P. Whelan

  • Development of a preventive vaccine for Ebola virus infection in primates

    Nancy J. Sullivan;Anthony Sanchez;Pierre E. Rollin;Zhi Yong Yang

  • Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.

    Steven M. Jones;Heinz Feldmann;Heinz Feldmann;Ute Ströher;Ute Ströher;Joan B. Geisbert

  • LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

    Unknown

  • Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

    Nancy J. Sullivan;Thomas W. Geisbert;Joan B. Geisbert;Ling Xu

  • Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury

    Zhi Yong Yang;Henricus J. Duckers;Nancy J. Sullivan;Anthony Sanchez

  • A Recombinant Vesicular Stomatitis Virus Ebola Vaccine — Preliminary Report

    Jason A. Regules;John H. Beigel;Kristopher M. Paolino;Jocelyn Voell

  • Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody

    Davide Corti;John Misasi;Sabue Mulangu;Daphne A. Stanley

  • Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine.

    Kai Wu;Anne P Werner;Matthew Koch;Angela Choi

  • Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge

    Daphne A Stanley;Anna N Honko;Anna N Honko;Clement Asiedu;John C Trefry

  • Chimpanzee Adenovirus Vector Ebola Vaccine

    Julie E. Ledgerwood;Adam D. DeZure;Daphne A. Stanley;Emily E. Coates

  • mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron

    Unknown

  • A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

    Katie Ewer;Tommy Rampling;Navin Venkatraman;Georgina Bowyer

  • Neutralizing Antibody Fails to Impact the Course of Ebola Virus Infection in Monkeys

    Wendelien B Oswald;Thomas W Geisbert;Kelly J Davis;Joan B Geisbert

  • A DNA Vaccine for Ebola Virus Is Safe and Immunogenic in a Phase I Clinical Trial

    Julie E Martin;Nancy J Sullivan;Mary E Enama;Ingelise J Gordon

  • Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule.

    Nancy J. Sullivan;Julie E. Martin;Barney S. Graham;Gary J. Nabel

  • Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates.

    Kizzmekia S. Corbett;Martha C. Nason;Britta Flach;Matthew Gagne

  • Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529

    Unknown

  • CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates

    Nancy J Sullivan;Lisa Hensley;Clement Asiedu;Thomas W Geisbert

  • Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge

    Thomas W. Geisbert;Michael Bailey;Lisa Hensley;Clement Asiedu

  • Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs.

    Nancy J Sullivan;Thomas W Geisbert;Joan B Geisbert;Devon J Shedlock

  • Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial

    Milagritos D. Tapia;Samba O. Sow;Kirsten E. Lyke;Fadima Cheick Haidara

Frequent Co-Authors

Barney S. Graham
Barney S. Graham Morehouse School of Medicine
Anthony Sanchez
Anthony Sanchez University of Perpignan
Zhi-Yong Yang
Zhi-Yong Yang ModeX Therapeutics LLC
Peter D. Kwong
Peter D. Kwong Columbia University Medical Center
Lawrence Shapiro
Lawrence Shapiro Columbia University
Tongqing Zhou
Tongqing Zhou National Institutes of Health
Richard A. Koup
Richard A. Koup National Institute of Allergy and Infectious Diseases
Kizzmekia S. Corbett
Kizzmekia S. Corbett Harvard University
Karin Loré
Karin Loré Karolinska Institute
Wei Shi
Wei Shi Monash University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers related to Microbiology often leads students to consider diverse healthcare and scientific fields. For those interested in administrative roles within healthcare settings, the fastest online medical billing and coding certificate programs offer a quick pathway into essential medical office functions. These programs provide specialized skills that complement microbiological knowledge in healthcare environments.

Many students also pursue advanced education through various online medical programs, which allow flexibility while expanding expertise in areas like public health, clinical research, or laboratory technology. These programs can be pivotal for microbiologists aiming for roles in healthcare innovation or patient care management.

For those considering public health careers, the fastest and easiest online MPH programs enable swift entry into the field, often with part-time study options. An MPH degree can enhance opportunities in epidemiology, environmental health, and policy-making, areas closely aligned with microbiology.

Additionally, careers such as child life specialists demonstrate unique intersections between healthcare and support services. Understanding how much do child life specialists make can help microbiology graduates evaluate diverse healthcare career pathways, especially those focused on patient experience and well-being.

Best Scientists Citing Nancy J. Sullivan

Trending Scientists